Two Sigma Investments, LP Repligen Corp Transaction History
Two Sigma Investments, LP
- $42.8 Billion
- Q1 2025
A detailed history of Two Sigma Investments, LP transactions in Repligen Corp stock. As of the latest transaction made, Two Sigma Investments, LP holds 225,306 shares of RGEN stock, worth $25.7 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
225,306
Previous 359,039
37.25%
Holding current value
$25.7 Million
Previous $51.7 Million
44.53%
% of portfolio
0.07%
Previous 0.12%
Shares
18 transactions
Others Institutions Holding RGEN
# of Institutions
493Shares Held
57.5MCall Options Held
75.6KPut Options Held
521K-
Black Rock Inc. New York, NY7.57MShares$864 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.57MShares$863 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$580 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$193 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.67MShares$191 Million0.04% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $6.33B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....